Back to Avoro Capital Advisors LLC Avoro Capital Advisors LLC

ARWRARWR
Showing 8 of 13 quarters

Position history for Avoro Capital Advisors LLCAvoro Capital Advisors LLC's holdings in ARROWHEAD PHARMACEUTICALS IN

Avoro Capital Advisors LLC holds 11.4M shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), worth $925.6M as of 2026-Q2. The position was increased (+6.1% shares). ARWR represents 8.3% of Avoro Capital Advisors LLC's portfolio.

Current Value

$925.6M

Current Shares

11.4M

Total Value Change

+$753.4M

Total Shares Change

+2.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
11.4M
+6.1%
$925.6M8.3%$81.51
67
2026-Q1
Increased
10.7M
+0.7%
$670.9M6.6%$64.10
63
2025-Q4
Decreased
10.6M
-2.5%
$705.4M6.9%$67.25
0
2025-Q3
Increased
10.9M
+2.8%
$375.9M4.9%$33.78
60
2025-Q2
Decreased
10.6M
-4.6%
$167.5M2.9%$16.08
0
2025-Q1
Unchanged
11.1M
0.0%
$141.6M2.2%$13.82
0
2024-Q4
Increased
11.1M
+25.0%
$208.9M3.0%$18.61
65
2024-Q3
Unchanged
8.9M
0.0%
$172.2M2.5%$19.67
0

Other major holders of ARWR: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used